
Innovating to support your opioid reduction efforts and ERAS Protocols.
Published on September 1, 2021
This patent-pending combination sterile preparation consists of three non-opioid drugs in a ready-to-administer syringe: bupivacaine HCI, dexamethasone sodium phosphate, and epinephrine.
